Sorafenib in Newly Diagnosed High Grade Glioma

Clinical trial NCT00884416 · COMPLETED

Trial details

NCT number: NCT00884416
Sponsor: University Hospital, Geneva
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Gliosarcoma Anaplastic Astrocytoma Anaplastic Oligoastrocytoma Anaplastic Oligodendroglioma

Start date: 2009-03-01
Primary completion: 2011-12-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.